Everence Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,090
| Closed | -$469K | – | 921 |
|
|
2026
Q1 | $469K | Hold |
2,090
| – | – | 0.03% | 396 |
|
|
2025
Q4 | $503K | Hold |
2,090
| – | – | 0.03% | 393 |
|
|
2025
Q3 | $572K | Hold |
2,090
| – | – | 0.03% | 352 |
|
|
2025
Q2 | $539K | Hold |
2,090
| – | – | 0.03% | 353 |
|
|
2025
Q1 | $468K | Buy |
2,090
+420
| +25% | +$98K | 0.03% | 387 |
|
|
2024
Q4 | $382K | Sell |
1,670
-700
| -30% | -$169K | 0.02% | 467 |
|
|
2024
Q3 | $579K | Hold |
2,370
| – | – | 0.04% | 379 |
|
|
2024
Q2 | $507K | Hold |
2,370
| – | – | 0.04% | 381 |
|
|
2024
Q1 | $469K | Hold |
2,370
| – | – | 0.03% | 423 |
|
|
2023
Q4 | $408K | Sell |
2,370
-4,380
| -65% | -$673K | 0.03% | 458 |
|
|
2023
Q3 | $998K | Buy |
6,750
+4,380
| +185% | +$792K | 0.08% | 211 |
|
|
2023
Q2 | $500K | Hold |
2,370
| – | – | 0.04% | 351 |
|
|
2023
Q1 | $519K | Hold |
2,370
| – | – | 0.04% | 351 |
|
|
2022
Q4 | $493K | Sell |
2,370
-1,648
| -41% | -$362K | 0.04% | 376 |
|
|
2022
Q3 | $877K | Hold |
4,018
| – | – | 0.08% | 209 |
|
|
2022
Q2 | $842K | Hold |
4,018
| – | – | 0.08% | 210 |
|
|
2022
Q1 | $974K | Buy |
4,018
+2,520
| +168% | +$610K | 0.07% | 214 |
|
|
2021
Q4 | $390K | Sell |
1,498
-1,960
| -57% | -$509K | 0.03% | 505 |
|
|
2021
Q3 | $911K | Hold |
3,458
| – | – | 0.07% | 217 |
|
|
2021
Q2 | $852K | Hold |
3,458
| – | – | 0.07% | 231 |
|
|
2021
Q1 | $671K | Hold |
3,458
| – | – | 0.06% | 267 |
|
|
2020
Q4 | $735K | Hold |
3,458
| – | – | 0.07% | 229 |
|
|
2020
Q3 | $593K | Hold |
3,458
| – | – | 0.07% | 249 |
|
|
2020
Q2 | $556K | Hold |
3,458
| – | – | 0.07% | 255 |
|
|
2020
Q1 | $509K | Hold |
3,458
| – | – | 0.07% | 235 |
|
|
2019
Q4 | $536K | Hold |
3,458
| – | – | 0.08% | 268 |
|
|
2019
Q3 | $467K | Hold |
3,458
| – | – | 0.08% | 285 |
|
|
2019
Q2 | $422K | Hold |
3,458
| – | – | 0.07% | 311 |
|
|
2019
Q1 | $360K | Hold |
3,458
| – | – | 0.06% | 347 |
|
|
2018
Q4 | $394K | Hold |
3,458
| – | – | 0.09% | 239 |
|
|
2018
Q3 | $399K | Hold |
3,458
| – | – | 0.08% | 264 |
|
|
2018
Q2 | $358K | Hold |
3,458
| – | – | 0.08% | 278 |
|
|
2018
Q1 | $341K | Hold |
3,458
| – | – | 0.08% | 274 |
|
|
2017
Q4 | $293K | Buy |
+3,458
| New | +$286K | 0.06% | 309 |
|
Other funds holding RMD
Everence Capital Management's RMD Position: Q2 2026 in Review
Everence Capital Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 2,090 shares — an estimated $469K sold.
Everence Capital Management first reported a position in RMD in Q4 2017 and held it in 34 quarters. The position peaked at $998K in Q3 2023. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Everence Capital Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
- Everence Capital Management sold 2,090 ResMed shares in Q2 2026, an estimated $469K.
- Everence Capital Management first reported a position in ResMed in Q4 2017 and held it in 34 quarters.
- Everence Capital Management's ResMed position peaked at $998K in Q3 2023.
- 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.